This is the authors' abstract. We don't add key points for this paper.
In this commentary, we open the debate on what can be expected from artificial intelligence (AI) in the diagnosis of hematologic cancers. We discuss the key factors that make AI solutions robust, trustworthy, and, above all, generalizable, with particular emphasis on the importance of dataset quality in shaping the performance and effectiveness of AI models.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Syrykh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: